← Back to catalogue
Research draft

iatrogenesis

vr.tr.iatrogenesis · XCT.STA

Let an agent explain iatrogenesis and patient safety, help people report suspected adverse effects and seek care, and describe safety systems and rights without giving individual medical or legal advice.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain iatrogenesis and patient safety, help people report suspected adverse effects and seek care, and describe safety systems and rights without giving individual medical or legal advice.

Harm to a patient caused by medical examination, treatment or advice, including adverse drug effects, complications of procedures, hospital-acquired infections and errors, whether or not avoidable; iatrogenic harm is studied in patient safety, reported through pharmacovigilance and incident systems, and reduced through safety practices.

What it is for: Understanding and reducing harm from medical care.

It can be explain types of iatrogenic harm; route suspected adverse effects to care and reporting; explain patient safety systems; explain patient rights and complaint routes.

Distinguishing features

Caused by care

Avoidable or unavoidable

Reported and analysed

Target of safety systems

What it looks like

Not physical; harms recorded in clinical and safety records.

How it is recognised

Harm linked to treatment

Adverse effects and complications

Disease progression is not iatrogenic

Related models

is a kind of - category

health problem

is a kind of - category

health risk

is related to - drug-induced harm

medication

is related to - device-related harm

medical device

In practice

Families and kinds

adverse drug reactions

procedural complications

healthcare-associated infections

diagnostic and medication errors

overtreatment and overdiagnosis

Standards and regulation

Pharmacovigilance systems such as the Yellow Card scheme and FDA MedWatch

WHO patient safety frameworks

National patient rights and complaints law

Failure modes and hazards

Unreported adverse effects

Blame culture hindering learning

Agents giving medical or legal advice

Also called

Drug-induced pseudolymphomaSubacute myelo-optic neuropathydrug-induced lung diseaseDrug-induced pigmentationProcedural Toxicityadverse effectcomplication of radiotherapyadverse drug reactionreactogenicitydrug resistancedrug-induced enteritisWarfarin necrosishypertension secondary to drugdrug eruptionmedication overuse headacheanticholinergic toxidromeoral galvanismvaccine-associated enhanced respiratory diseaselivedoid dermatitissteinstrasseharmPost-intensive care syndromeantibody-dependent enhancementimplant failurepostoperative complicationspostsurgical testicular hypofunctiontransplant-related diseaseadherence syndromeDialytraumaPost-LASIK ectasiaabortion complicationVein graft failureintraoperative complicationsIatrogenic calcinosis cutisinjection fibrosisinjection site reactioncontact lens complicationsPUVA-induced acrobullous dermatosisPUVA keratosisPUVA lentigines

+108

Where this came from

wikidata · CC0 1.0

Source repository Registry entry point

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Now Suspected harm.

Care first.

Urgent

Serious reactions.

Urgent

Serious reactions.

  1. Is the person experiencing a serious reaction or complication now? boundary
  2. Should emergency or urgent care be sought? action

Report

Reporting.

Report

Reporting.

  1. How can a suspected adverse drug effect or device problem be reported here? provenance
  2. Should the prescriber be informed before stopping a medicine? boundary
Understand Types of harm.

General information.

Types

Kinds of iatrogenic harm.

Types

Types.

  1. What kinds of harm can arise from care, and how common are they, according to safety studies? provenance
  2. Is the user asking about their own treatment? boundary

Avoidable

Avoidable or not.

Avoidable

Avoidability.

  1. How do safety bodies distinguish avoidable harm from known risks of treatment? definition
  2. How is consent to known risks handled? provenance
Systems Patient safety.

Learning systems.

Safety

Safety practices.

Safety

Safety practices.

  1. Which practices reduce iatrogenic harm, such as checklists and medication reconciliation? provenance
  2. How are incidents investigated and learned from? provenance

Overuse

Overdiagnosis.

Overuse

Overuse.

  1. What are overdiagnosis and overtreatment, and which initiatives address them? provenance
  2. How can patients discuss necessity of tests with clinicians? action
Rights After harm.

Rights and routes.

Complaints

Complaints and redress.

Complaints

Complaints.

  1. How can a patient complain about care or seek an explanation here? provenance
  2. Which duty of candour rules apply? provenance

Legal

Legal routes.

Legal

Legal routes.

  1. Which routes to compensation exist, in general terms? provenance
  2. Is the user asking for legal advice on their own case? boundary

What the second pass must settle

  • Should adverse drug reactions be a separate entry?
  • How should reporting systems be localised?
  • How should patient rights be linked?
Draft as JSON